Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Special Investigation for ABRYSVO Intramuscular Injection -Investigation in Pregnant Women and Infants-

NCT06482099 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT06482099
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06482099 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Special Investigation for ABRYSVO Intramuscular Injection -Investigation in Pregnant Women and Infants-
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
October 1, 2024
Completion date
February 27, 2026
Enrollment
497 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

respiratory tract infection